Epizyme (EPZM)
NASDAQ:EPZM
Holding EPZM?
Track your performance easily

Epizyme (EPZM) Financial Statements

0 Followers

Epizyme Financial Overview

Epizyme's market cap is currently ―. The company's EPS TTM is $-1.727; its P/E ratio is -0.85; Epizyme is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 27.53M$ 8.70M$ 11.58M$ 5.20M$ 13.01M
Gross Profit$ 22.33M$ 6.10M$ 8.43M$ 3.20M$ 10.52M
EBIT$ -29.76M$ -49.50M$ -44.58M$ -59.74M$ -58.28M
EBITDA$ -28.48M$ -48.21M$ -43.25M$ -58.42M$ -56.97M
Net Income Common Stockholders$ -35.74M$ -55.51M$ -50.65M$ -65.83M$ -64.36M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 144.41M$ 176.79M$ 199.73M$ 221.29M$ 244.01M
Total Assets$ 264.16M$ 312.19M$ 289.00M$ 332.27M$ 352.55M
Total Debt$ 88.99M$ 233.04M$ 234.58M$ 235.74M$ 237.23M
Net Debt$ -55.42M$ 56.25M$ 34.85M$ 14.45M$ -6.78M
Total Liabilities$ 284.44M$ 301.06M$ 309.69M$ 316.89M$ 284.92M
Stockholders Equity$ 11.12M$ 15.38M$ 67.63M$ 123.03M$ 184.90M
Cash Flow-
Free Cash Flow$ -54.81M$ -59.20M$ -52.06M$ -42.81M$ -56.77M
Operating Cash Flow$ -54.81M$ -59.19M$ -51.97M$ -42.64M$ -56.67M
Investing Cash Flow$ 48.71M$ -44.19M$ 18.18M$ 66.64M$ 60.98M
Financing Cash Flow$ -257.00K$ 82.46M$ 7.60M$ 20.35M$ 2.15M
Currency in USD

Epizyme Earnings and Revenue History

Epizyme Debt to Assets

Epizyme Cash Flow

Epizyme Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis